Anaptysbio, Inc (ANAB) earnings
Quarterly results of Anaptysbio, Inc as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Latest quarter: Q1 FY2026
In Q1 FY2026 (ended March 31, 2026) Anaptysbio, Inc reported revenue of $25.6M (-8% on the same quarter a year earlier) and a net loss of $52.9M.
Diluted earnings per share were -$1.84.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q1 FY2026 | $25.6M | -8% | -$52.9M | -$1.84 |
| Q4 FY2025 | $108.2M | +151.1% | $49.6M | - |
| Q3 FY2025 | $76.3M | +154.3% | $15.1M | $0.52 |
| Q2 FY2025 | $22.3M | +102.9% | -$38.6M | -$1.34 |
| Q1 FY2025 | $27.8M | - | -$39.3M | -$1.28 |
| Q4 FY2024 | $43.1M | - | -$21.8M | - |
| Q3 FY2024 | $30M | - | -$32.9M | -$1.14 |
| Q2 FY2024 | $11M | - | -$46.7M | -$1.71 |
Results filings
- Transition-period annual report 10-KT
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report (amended) 10-K/A
What were Anaptysbio, Inc's latest quarterly results?
For Q1 FY2026, which ended March 31, 2026, Anaptysbio, Inc reported revenue of $25.6M and a net loss of $52.9M. The figures come from its filing with the SEC.
Is Anaptysbio, Inc's revenue growing?
Revenue in Q1 FY2026 was $25.6M, down 8% from $27.8M in the same quarter a year earlier.
Get an email when ANAB reports
Follow ANAB and we email you its next results the day they are filed, with the numbers explained.